Inventor · disambiguated record
Daniel Scott
Also filed as: SCOTT DANIEL · SCOTT DANIEL M
14 granted patents·10 pending applications·79 citations·filing 2005–2024
91Inventor score
Files withSUNESIS PHARMACEUTICALS INC5BIOGEN MA INC4VIRACTA THERAPEUTICS INC4BIOGEN IDEC INC3BUI MINNA2
Top patents by PatentIndex Score
24 records- 0192US9790229B2Bruton's tyrosine kinase inhibitorsBIOGEN MA INC·Filed 2016·Granted Oct 17, 2017·11 cites·21 claims
- 0291US8785440B2Bruton's tyrosine kinase inhibitorsBUI MINNA·Filed 2010·Granted Jul 22, 2014·20 cites·20 claims
- 0389US9249146B2Bruton'S tyrosine kinase inhibitorsBIOGEN IDEC INC·Filed 2014·Granted Feb 2, 2016·9 cites·25 claims
- 0484US9181191B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN IDEC INC·Filed 2012·Granted Nov 10, 2015·3 cites·38 claims
- 0584US9029359B2Heteroaryl Btk inhibitorsBUI MINNA·Filed 2010·Granted May 12, 2015·12 cites·18 claims
- 0684US2024246988A1Bruton's tyrosine kinase inhibitorsVIRACTA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0784US2024294524A1Heterocyclic compounds useful as pdk1 inhibitorsVIRACTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0883US9273028B2Heterocyclic tyrosine kinase inhibitorsHOPKINS BRIAN T·Filed 2011·Granted Mar 1, 2016·6 cites·8 claims
- 0982US10577374B2Bruton's tyrosine kinase inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2017·Granted Mar 3, 2020·2 cites·18 claims
- 1082US8349849B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN IDEC INC·Filed 2009·Granted Jan 8, 2013·6 cites·21 claims
- 1180US10030016B2Heterocyclic compounds useful as PDK1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2015·Granted Jul 24, 2018·2 cites·16 claims
- 1278US2023046457A1Bruton's tyrosine kinase inhibitorsVIRACTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1377US8546359B2Bicyclic aryl sphingosine 1-phosphate analogsCaldwell richard d·Filed 2012·Granted Oct 1, 2013·4 cites·31 claims
- 1477US2023113598A1Heterocyclic compounds useful as pdk1 inhibitorsVIRACTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1574US8269043B2Bicyclic aryl sphingosine 1-phosphate analogsCaldwell richard d·Filed 2009·Granted Sep 18, 2012·2 cites·19 claims
- 1670US9546165B2Heterocyclic compounds useful as PDK1 inhibitorsARNDT JOSEPH·Filed 2010·Granted Jan 17, 2017·2 cites·12 claims
- 1770US2021070752A1Heterocyclic compounds useful as pdk1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1870US2020399283A1Bruton's tyrosine kinase inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1963US2019119268A1Heterocyclic compounds useful as pdk1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2060US10081646B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2017·Granted Sep 25, 2018·0 cites·26 claims
- 2155US9708353B2Heterobicyclic sphingosine 1-phosphate analogsBIOGEN MA INC·Filed 2015·Granted Jul 18, 2017·0 cites·29 claims
- 2250US2017027956A1Heterocyclic tyrosine kinase inhibitorsBIOGEN MA INC·Filed 2016·Application pending·0 cites
- 2342US2008234271A1Arylphenylamino- and Arylphenylether-Sulfide Derivatives, Useful For the Treatment of Inflammatory and Immune Diseases, and Pharmaceutical Compositions Containing ThemICOS CORP·Filed 2005·Application pending·0 cites
- 2441US2007259863A1Arylphenylamino-,Arylphenylamide-, and Arylphenylether-Sulfide DerivativesICOS CORP·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel Scott files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →